Taurus Meds Review

Taurus Meds is the consumer platform, not the treating practice or dispensing pharmacy. Current terms identify Taurus Medical, Inc. as the operator, OpenLoop Health, Inc. as the partner MSO, and four possible pharmacies. The site does not say which professional entity or pharmacy will handle an individual order before intake.

OpenLoop's telehealth consent says care may use video, telephone, or asynchronous technology. The treating professional entity is identified at the visit, the clinician uses professional judgment, and a prescription is not guaranteed. The platform does not provide emergency care.

The current TRT funnel offers testosterone cypionate injection plus anastrozole and enclomiphene orally disintegrating tablets plus anastrozole. Either combination costs $149 for one month, $714 for six months, or $1,188 for twelve months. The plan-level monthly rates average to Avg. $122/mo.

Neither TRT price is assigned to testosterone cypionate or enclomiphene alone. The current product names include anastrozole, so both remain multi-ingredient editorial cards without a single-ingredient medication comparison. Exact strength, quantity, additives, and prescribed anastrozole use are not public before evaluation.

TRT route copy conflicts. The live funnel describes weekly subcutaneous testosterone cypionate, while the product page uses intramuscular language. The review does not choose a route from conflicting marketing copy. The prescription label and clinician instructions should control.

The intake accepts a gel preference, but the current product-pricing object resolves only injection and pill plans. An older landing page lists testosterone gel and Oral Sermorelin+, yet the page also assigns weekly intramuscular-injection text to oral and gel products. Those entries do not become active treatment cards.

TRT testing costs also vary by page. The home page advertises a free initial testosterone test, an older landing page charges $49 for bloodwork and consultation, and the current funnel places the initial test and clinician evaluation within the $149 order. Product pages say routine blood testing is included. The final laboratory panel, vendor, cadence, and retest charges require checkout confirmation.

The three current longevity injections are NAD+, sermorelin, and glutathione. Taurus groups all three under peptide therapy even though NAD+ and glutathione are not peptides. The review keeps the provider's category context but uses each actual ingredient name.

Each longevity product has a $179 one-month option and a three-month total of $437. The three-month term combines a $79 first month with two $179 months. The effective monthly rates of $179 and $145.67 average to Avg. $162/mo.

The $79 first-month marketing needs a qualification. The product pages display it without an obvious term condition, while the current checkout code applies that structure to the three-month supply and leaves the one-month plan at $179. The review preserves both totals instead of presenting $79 as an ordinary monthly price.

The NAD+ and glutathione pages each publish 200 mg/mL in a 5 mL bottle. The sermorelin page publishes 2 mcg/mL in a 5 mL bottle. The live intake labels the approved medication route subcutaneous. The review reports the displayed sermorelin concentration as written and does not infer a correction.

All three longevity pages describe compounded injections and say the home kit and shipping are included. They do not identify the assigned pharmacy, ingredient source, additives, dose schedule, syringe details, beyond-use date, lot, testing laboratory, or a linked certificate of analysis.

Compounded drugs are not FDA approved, and FDA does not verify their safety, effectiveness, or quality before marketing. Taurus's broad home-page statement about FDA-approved medications therefore should not be applied to its compounded longevity or ED formulas.

FDA currently warns compounders not to use dietary-supplement-grade glutathione for injectable drugs after reports tied to a specific supplier lot. The notice does not identify Taurus or prove its product used that lot. It makes the missing pharmacy assignment, ingredient source, lot, and certificate information important questions for any injectable glutathione order.

Taurus's current headline ED product is a four-part liquid sold under the Charge name. Its dedicated landing page lists sildenafil, tadalafil, vardenafil, and apomorphine. The live checkout instead lists sildenafil, tadalafil, apomorphine, and L-citrulline. The unresolved fourth ingredient prevents a defensible catalog match or price comparison.

The four-part checkout has five monthly dose quantities and matching three-month bundles. At five doses per month, the listed totals are $99 for one month or $199 for fifteen doses over three months. Higher usage tiers change both the total and per-dose rate, so they cannot be blended into one general average.

A separate current product page and the same funnel offer a three-part dissolvable tablet with sildenafil 110 mg, tadalafil 22 mg, and apomorphine 3 mg. At six doses per month, $101.94 for one month and $269.82 for eighteen doses over three months produce Avg. $96/mo. The multi-ingredient formula remains outside single-drug comparisons.

The treatment pages repeatedly say there is no membership fee or hidden fee. Section 28 of the current terms instead states that account or membership use carries a recurring $17.99 fee per billing period and describes it as non-refundable except where law requires. The checkout should show whether and how that charge applies to the selected plan.

Subscriptions renew automatically until cancelled. The refund policy requires cancellation at least 72 hours before the billing date. A later request can produce one more charge, with cancellation taking effect on the following billing date. Ordinary cancellation does not create a refund for the current period.

The refund policy says a patient medically disqualified by the clinician receives a full refund. Shipped medications are final sale, bloodwork is non-refundable once ordered, and damaged or incorrect items may qualify for replacement. The page also contains copied weight-loss language that does not match the catalog reviewed here.

Taurus's privacy page says Taurus Medical and OpenLoop intend to comply with HIPAA and HITECH. Section 1 of the terms says the services are not tailored for HIPAA and bars use when HIPAA would apply. The documents do not reconcile those positions, and the privacy page contains a broken template contact address.

The four pharmacies named in the terms are RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, and Triad Rx. Naming potential pharmacies improves traceability, but the site does not map products or states to them. The label on the dispensed medication remains the patient-specific source.

Shipping is advertised as free. Depending on the page, Taurus says medication ships within 24 hours or uses two-day, rush, or overnight delivery. No universal carrier, cutoff time, temperature-control procedure, lost-package process, or replacement timeline is public for every product.

The TRT funnel has state-specific exclusions for testosterone injection and a separate Massachusetts supply-chain notice. ED and longevity flows collect the patient's state but do not publish a complete product-by-state table. Availability therefore depends on the treatment, clinician licensure, prescribing rules, pharmacy service, and delivery location.

The longevity pages say no insurance is required and describe the products as HSA or FSA eligible. OpenLoop's consent also says outside laboratory services may bill separately. Reimbursement is not guaranteed, and the checkout and plan administrator should confirm the selected expense.

Taurus publishes support@taurusmeds.com, a mailing address, patient login, and repeated 24/7 clinical-support claims. It does not publish a direct Taurus support phone, support hours, response-time promise, or a clear escalation route for medical, billing, laboratory, pharmacy, shipping, or privacy problems.

No affiliate tracking link has been issued for the pending Katalys relationship, and no customer promotion has been verified as compatible with a future tracking link. This unpublished draft therefore uses the canonical Taurus URL and displays no promotional message.